A novel pressure of Extreme Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) illness (COVID-19) has been just lately recognized as an infectious illness affecting the respiratory system of people. This illness is attributable to SARS-CoV-2 that was recognized in Chinese language sufferers having extreme pneumonia and flu-like signs. COVID-19 is a contagious illness that spreads quickly by way of droplet particles arising by means of sneezing and coughing motion of an contaminated particular person.
The reviews of asymptomatic carriers modified the situation of symptom based-diagnosis in COVID-19 and intensified the necessity for correct analysis of nearly all of the inhabitants to fight the fast transmission of virus. The analysis of constructive instances is important to make sure immediate care to affected folks and in addition to curb additional unfold of an infection within the inhabitants. Amassing samples on the proper time and from the precise anatomical web site is essential for correct molecular analysis. After the entire genome sequence was obtainable, China formulated RT-PCR as a main diagnostic process for detecting SARS-CoV-2. Many in-house and business diagnostic kits have been developed or are below improvement which have a possible to decrease the burden of analysis on the first diagnostic strategies like RT-PCR. Serological primarily based analysis is one other broad class of testing that may detect totally different serum antibodies like IgG, IgM, and IgA in an contaminated affected person. PCR-based diagnostic procedures which can be generally used for pathogen detection want refined machines and help of a technical knowledgeable.
Regardless of their dependable accuracy, they don’t seem to be cost-effective exams, which a typical man can afford, so it turns into crucial to search for different diagnostic approaches, which could possibly be value efficient, fast, and delicate with constant accuracy. To make such diagnostics obtainable to the frequent man, many strategies might be exploited amongst, that are Level of Care (POC), often known as mattress facet testing, which is growing as a transportable and promising instrument in pathogen analysis. Different lateral stream assay (LFA)-based strategies like SHERLOCK, CRISPR-Cas12a (AIOD-CRISPR), and FNCAS9 editor-limited uniform detection assay (FELUDA), and so on. have proven promising ends in fast detection of pathogens. Analysis holds a vital significance within the pandemic scenario when there isn’t any potential drug for the pathogen obtainable out there. This overview sums up the totally different diagnostic approaches designed or proposed to fight the disaster of widespread analysis because of the sudden outbreak of a novel pathogen, SARS-CoV-2 in 2019.
An Update on Molecular Diagnostics for COVID-19
Simultaneous Inhibition of Ornithine Decarboxylase 1 and Pyruvate Kinase M2 Exerts Synergistic Results Towards Hepatocellular Carcinoma Cells
Objective: Beforehand, we confirmed that lactate promoted the proliferation and mobility of hepatocellular carcinoma (HCC) cells by growing the expression of ornithine decarboxylase 1 (ODC1). On this research, we decided the connection between ODC1 and pyruvate kinase M2 (PKM2, a key lactate metabolism enzyme), and decided the mixed results of difluoromethylornithine (DFMO; an ODC1 inhibitor) and compound 3k (a PKM2 inhibitor) on HCC cells.
Strategies: First, the connection between PKM2 and ODC1 was analyzed utilizing Western blotting, Cell Counting Package (CCK)-Eight assays, transwell assays, bioinformatics, quantitative real-time fluorescent PCR (qRT-PCR), and immunohistochemical staining. Thereafter, the ODC1 inhibitor DFMO and the PKM2 inhibitor compound 3k had been employed. Their mixed results on HCC cell proliferation and mobility had been evaluated by way of CCK-Eight assay, stream cytometry, a subcutaneous xenograft tumor mannequin in mice, wound therapeutic assays, and transwell assays. Moreover, the consequences of DFMO and compound 3k on the epithelial-mesenchymal transition phenotype and the AKT/GSK-3β/β-catenin pathway had been explored utilizing Western blotting and immunofluorescence.
Outcomes: PKM2 knockdown considerably decreased the ODC1 expression, and the proliferation and invasion of HCC cells, whereas ODC1 overexpression reversed the inhibitory results of PKM2 knockdown. Equally, inhibition of ODC1 additionally decreased the expression of PKM2 by way of lowering the c-myc-induced transcription. PKM2 was co-expressed with ODC1 in HCC samples, whereas concurrently upregulated PKM2 and ODC1 led to the poorest survival final result. DFMO and compound 3k synergistically inhibited HCC cell proliferation, induced apoptosis, and suppressed cell mobility, in addition to the EMT phenotype and the AKT/GSK-3β/β-catenin pathway. The AKT activator SC79 reversed the inhibitory results.
Conclusion: PKM2/ODC1 are concerned in a constructive suggestions loop. The simultaneous inhibition of ODC1 and PKM2 utilizing DFMO and compound 3k exerts synergistic results in opposition to HCC cells by way of the AKT/GSK-3β/β-catenin pathway. Thus, DFMO mixed with compound 3k could also be a novel efficient technique for treating HCC.
The variety of pattern was 6. (2) The first passage of human umbilical twine mesenchymal stem cells (hUCMSCs) had been collected and cultured to the third passage with the conventional exosomes being extracted from the hUCMSCs after cultured for 48 h. One other batch of hUCMSCs within the third passage was collected and stimulated with inflammatory wound tissue homogenate supernatant of 30, 50, and 100 μg/mL complete protein and regular pores and skin tissue homogenate supernatant of 30, 50, and 100 μg/mL complete protein, respectively.
Description: A polyclonal antibody against GABARAP. Recognizes GABARAP from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB
Description: A polyclonal antibody against GABARAP. Recognizes GABARAP from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:100-1:200
Description: Gamma-aminobutyric acid A receptors [GABA(A) receptors] are ligand-gated chloride channels that mediate inhibitory neurotransmission. This gene encodes GABA(A) receptor-associated protein, which is highly positively charged in its N-terminus and shares sequence similarity with light chain-3 of microtubule-associated proteins 1A and 1B. This protein clusters neurotransmitter receptors by mediating interaction with the cytoskeleton.
Description: Gamma-aminobutyric acid A receptors [GABA(A) receptors] are ligand-gated chloride channels that mediate inhibitory neurotransmission. This gene encodes GABA(A) receptor-associated protein, which is highly positively charged in its N-terminus and shares sequence similarity with light chain-3 of microtubule-associated proteins 1A and 1B. This protein clusters neurotransmitter receptors by mediating interaction with the cytoskeleton.
Description: Gamma-aminobutyric acid A receptors [GABA(A) receptors] are ligand-gated chloride channels that mediate inhibitory neurotransmission. GABARAP is GABA(A) receptor-associated protein, which is highly positively charged in its N-terminus and shares sequence similarity with light chain-3 of microtubule-associated proteins 1A and 1B. This protein clusters neurotransmitter receptors by mediating interaction with the cytoskeleton.
Description: Gamma-aminobutyric acid A receptors [GABA(A) receptors] are ligand-gated chloride channels that mediate inhibitory neurotransmission. GABARAP is GABA(A) receptor-associated protein, which is highly positively charged in its N-terminus and shares sequence similarity with light chain-3 of microtubule-associated proteins 1A and 1B. This protein clusters neurotransmitter receptors by mediating interaction with the cytoskeleton.
Description: Gamma-aminobutyric acid receptor-associated protein is a protein that in humans is encoded by the GABARAP gene. Gamma-aminobutyric acid A receptors [GABA(A) receptors] are ligand-gated chloride channels that mediate inhibitory neurotransmission. This gene encodes GABA(A) receptor-associated protein, which is highly positively charged in its N-terminus and shares sequence similarity with light chain-3 of microtubule-associated proteins 1A and 1B. This protein clusters neurotransmitter receptors by mediating interaction with the cytoskeleton.
Description: GABARAP is cleaved at its carboxyl terminus, which leads to conjugation by either of the phospholipids phosphatidylethanolamine or phosphatidylserine. This processing converts GABARAP from a type I to a type II membrane bound form involved in autophagosome biogenesis. Processing of GABARAP involves cleavage by Atg4 family members followed by conjugation by the E1 and E2 like enzymes Atg7 and Atg3.
Description: Gamma-aminobutyric acid (GABA) is the main inhibitory transmitter by increasing a Cl-conductance that inhibits neuronal firing in the central nervous system (1). It has been shown to activate both ionotropic (GABAA) and metabotropic (GABAB) receptors as well as a third class of receptors called GABAC (2). GABARAPL2 (GABAA receptor-associated protein-like 2), also known as GATE16, was initially identified as a membrane transport modulator and is a mammalian ortholog to the autophagy protein ATG8 (3,4). It is thought that GABARAPL2 and other members of the ATG8 family act as scaffolds for assembly of the Unc-51 like kinase (ULK) complex in the formation of autophagosomes (5).
Description: Gamma-aminobutyric acid (GABA) is the main inhibitory transmitter by increasing a Cl-conductance that inhibits neuronal firing in the central nervous system (1). It has been shown to activate both ionotropic (GABAA) and metabotropic (GABAB) receptors as well as a third class of receptors called GABAC (2). GABARAPL2 (GABAA receptor-associated protein-like 2), also known as GATE16, was initially identified as a membrane transport modulator and is a mammalian ortholog to the autophagy protein ATG8 (3,4). It is thought that GABARAPL2 and other members of the ATG8 family act as scaffolds for assembly of the Unc-51 like kinase (ULK) complex in the formation of autophagosomes (5).
Description: A polyclonal antibody against GABARAPL1. Recognizes GABARAPL1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC
Description: A polyclonal antibody against GABARAPL2. Recognizes GABARAPL2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC
Description: A polyclonal antibody against GABARAPL2. Recognizes GABARAPL2 from Human, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:5000, IHC:1:1000-1:2000
Description: A polyclonal antibody against GABARAPL2. Recognizes GABARAPL2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:1000-1:5000
Description: A polyclonal antibody against GABARAPL1. Recognizes GABARAPL1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200
Description: A polyclonal antibody against GABARAPL1. Recognizes GABARAPL1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200
Description: A polyclonal antibody against GABARAPL1. Recognizes GABARAPL1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to APC/Cy7.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Biotin.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Dylight 350.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Dylight 405.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Dylight 488.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Dylight 594.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Dylight 633.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to FITC.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to HRP.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to PE/ATTO 594.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to PerCP.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to RPE .
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Streptavidin.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is unconjugated.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is unconjugated.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 390.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 488.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 565.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 594.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 633.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 655.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 680.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 700.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Alkaline Phosphatase.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to APC .
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to APC/Cy7.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Biotin.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Dylight 350.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Dylight 405.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Dylight 488.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Dylight 594.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Dylight 633.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to FITC.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to HRP.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to PE/ATTO 594.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to PerCP.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to RPE .
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Streptavidin.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is unconjugated.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is unconjugated.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 390.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 488.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 565.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 594.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 633.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 655.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 680.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to ATTO 700.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to Alkaline Phosphatase.
Description: A polyclonal antibody for GABARAP from Human | Mouse . The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of human GABARAP. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAP antibody is conjugated to APC .
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is unconjugated.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 390.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 488.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 565.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 594.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 633.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 655.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 680.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 700.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Alkaline Phosphatase.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to APC .
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to APC/Cy7.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Biotin.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Dylight 350.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Dylight 405.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Dylight 488.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Dylight 594.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Dylight 633.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to FITC.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to HRP.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to PE/ATTO 594.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to PerCP.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to RPE .
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Streptavidin.
Description: A polyclonal antibody for GABARAPL1 from Human | Mouse. The antibody is produced in rabbit after immunization with human synthetic peptide from the N-terminal of Human GABARAPL1 (aa. 5-16). The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is unconjugated.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is unconjugated.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 390.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 488.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 565.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 594.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 633.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 655.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 680.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to ATTO 700.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Alkaline Phosphatase.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to APC .
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to APC/Cy7.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Biotin.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Dylight 350.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Dylight 405.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Dylight 488.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Dylight 594.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to Dylight 633.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to FITC.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to HRP.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to PE/ATTO 594.
Description: A polyclonal antibody for GABARAPL1 from Human | Rat . The antibody is produced in rabbit after immunization with human synthetic peptide from the C-terminal of human GABARAPL1. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This GABARAPL1 antibody is conjugated to PerCP.
×
After cultured for 48 h, the exosomes stimulated with regular protein of 30, 50, and 100 μg/mL and exosomes stimulated with inflammatory protein of 30, 50, and 100 μg/mL had been extracted. Regular exosomes, exosomes stimulated with 30 μg/mL regular protein, and exosomes stimulated with 30 μg/mL inflammatory protein had been collected, the morphology was noticed by transmission electron microscope, the particle dimension was detected by nanoparticle monitoring analyzer, and the expressions of CD9 and CD63 had been detected by Western blotting.
Be First to Comment